SG11201803127TA - Nutritional compositions for promoting gut barrier function and ameliorating visceral pain - Google Patents

Nutritional compositions for promoting gut barrier function and ameliorating visceral pain

Info

Publication number
SG11201803127TA
SG11201803127TA SG11201803127TA SG11201803127TA SG11201803127TA SG 11201803127T A SG11201803127T A SG 11201803127TA SG 11201803127T A SG11201803127T A SG 11201803127TA SG 11201803127T A SG11201803127T A SG 11201803127TA SG 11201803127T A SG11201803127T A SG 11201803127TA
Authority
SG
Singapore
Prior art keywords
barrier function
nutritional compositions
visceral pain
gut barrier
promoting gut
Prior art date
Application number
SG11201803127TA
Other languages
English (en)
Inventor
Yan Zhong
Teartse Tim Lambers
Gabriele Gross
Sarmauli Manurung
Tol Eric A F Van
Rosaline Waworuntu
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of SG11201803127TA publication Critical patent/SG11201803127TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pediatric Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201803127TA 2015-11-06 2016-10-10 Nutritional compositions for promoting gut barrier function and ameliorating visceral pain SG11201803127TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/934,559 US9730969B2 (en) 2015-11-06 2015-11-06 Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
PCT/US2016/056207 WO2017078907A1 (en) 2015-11-06 2016-10-10 Nutritional compositions for promoting gut barrier function and ameliorating visceral pain

Publications (1)

Publication Number Publication Date
SG11201803127TA true SG11201803127TA (en) 2018-05-30

Family

ID=57200122

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201803127TA SG11201803127TA (en) 2015-11-06 2016-10-10 Nutritional compositions for promoting gut barrier function and ameliorating visceral pain

Country Status (12)

Country Link
US (2) US9730969B2 (zh)
EP (1) EP3370548A1 (zh)
JP (1) JP2018537434A (zh)
AR (1) AR106578A1 (zh)
AU (1) AU2016348173A1 (zh)
BR (1) BR112018008008A2 (zh)
CA (1) CA3004062A1 (zh)
MX (1) MX2018005590A (zh)
PH (1) PH12018500969A1 (zh)
SG (1) SG11201803127TA (zh)
TW (1) TW201729824A (zh)
WO (1) WO2017078907A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018202657A1 (en) * 2017-05-05 2018-11-08 Nestec S.A. Treatment of infant colic
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US20190208807A1 (en) * 2018-01-05 2019-07-11 Mead Johnson Nutrition Company Nutritional compositions containing milk-derived peptides and uses thereof
AU2021301341A1 (en) * 2020-06-30 2022-02-24 John SINN Allergen desensitisation
CN112568438B (zh) * 2020-12-07 2022-07-05 浙江华康药业股份有限公司 预防缓解肠道糖醇不耐受的甜味液及其制备方法和应用
CN115181683B (zh) * 2022-02-10 2023-10-03 江南大学 一株高富集有机锌的短双歧杆菌

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
DK165090D0 (da) 1990-07-09 1990-07-09 Kem En Tec As Konglomererede partikler
ZA92452B (en) 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
JPH09509165A (ja) 1994-02-16 1997-09-16 ファーミング ベスローテン フェンノートシャップ ミルクからのラクトフェリンの分離
SE9503926D0 (sv) 1995-11-07 1995-11-07 Pharmacia Biotech Ab Adsorptionsförfarande och separationsmedium
JP4743925B2 (ja) 1997-02-11 2011-08-10 エンタープライズ アイルランド トレーディング アズ バイオリサーチ アイルランド ラクトバシラス・サリバリウス由来の生体に有益な菌株及びそれより得られた抗菌剤
EP1087828B1 (en) 1998-06-18 2008-09-17 Upfront Chromatography A/S Expanded bed adsorption system
US6682744B1 (en) * 1999-08-09 2004-01-27 University Of Maryland Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
AU2001256610A1 (en) 2000-05-12 2001-11-20 Alimentary Health Limited A probiotic adhesin product, derived from lactobacillus
AU2001258238B2 (en) 2000-05-12 2005-06-23 Upfront Chromatography A/S A bed adsorption system
NZ536894A (en) 2000-08-08 2006-04-28 Vialactia Bioscience Nz Ltd Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
US6332533B1 (en) 2000-08-29 2001-12-25 H.H.H. Incorprorated Media holder mouse pad
DK1401289T3 (da) 2001-06-01 2005-07-18 Upfront Chromatography As Fraktionering af proteinholdige blandinger
US7368141B2 (en) 2002-03-07 2008-05-06 Upfront Chromatography A/S Process of isolating lactoferrin
JP4712289B2 (ja) 2003-08-26 2011-06-29 株式会社エイ・エル・エイ 免疫促進用組成物
WO2005034971A2 (en) 2003-10-08 2005-04-21 Masami Moriyama Antiviral agent
CN1663573B (zh) 2004-03-04 2010-04-28 青岛东海药业有限公司 一种稳定安全的微生态制剂及其制备方法和用途
CA2563702A1 (en) 2004-04-20 2005-12-01 The University Of Chicago Probiotic compounds from lactobacillus gg and uses therefor
AU2006230772A1 (en) 2004-04-20 2006-11-16 The University Of Chicago Probiotic compounds from lactobacillus GG and uses therefor
FR2875406B1 (fr) 2004-09-21 2007-01-05 Danisco Souche de lactobacillus acidophilus ayant des proprietes analgesiques au niveau du systeme gastro-intestinal
WO2007132359A2 (en) 2006-05-12 2007-11-22 Danisco A/S Composition containing lactobacillus sp. and a cannabinoid receptor and/or a opioid receptor agonist
JP5046684B2 (ja) 2007-02-28 2012-10-10 株式会社明治 腸管バリア機能の機能回復剤及び腸管バリア透過性の亢進阻害剤
FR2917623B1 (fr) 2007-06-22 2009-10-09 Lyoct Sa Lab Utilisation d'un probiotique pour la prevention des infections des voies respiratoires
PL2227539T3 (pl) 2007-12-26 2018-01-31 Lesaffre & Cie Kompozycja do żywności dla ludzi i/lub zwierząt, jej zastosowania, drożdże
EE05341B1 (et) 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
US8431528B2 (en) 2008-05-16 2013-04-30 University Of Maryland, Baltimore Antibacterial Lactobacillus GG peptides and methods of use
JP5526320B2 (ja) 2008-09-04 2014-06-18 国立大学法人旭川医科大学 腸管保護剤
EP2295535A1 (en) 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
KR20110124516A (ko) 2010-05-11 2011-11-17 포항공과대학교 산학협력단 유산균 배양액 추출물을 포함하는 염증관련질환 치료용 조성물
WO2011148219A1 (en) 2010-05-28 2011-12-01 Compagnie Gervais Danone Probiotic strains for use in improving the enteric nervous system
US20130251829A1 (en) 2012-03-23 2013-09-26 Mead Johnson Nutrition Company Probiotic derived non-viable material for infection prevention and treatment
US20150290261A1 (en) 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
US20150290260A1 (en) 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
US20150305385A1 (en) 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
US20150305384A1 (en) 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
CN104509864B (zh) 2015-01-20 2016-09-07 北京东方兴企食品工业技术有限公司 一种具有改善胃肠功能的营养保健食品及其制备方法

Also Published As

Publication number Publication date
US20170360855A1 (en) 2017-12-21
US20170128500A1 (en) 2017-05-11
TW201729824A (zh) 2017-09-01
AR106578A1 (es) 2018-01-31
WO2017078907A1 (en) 2017-05-11
CA3004062A1 (en) 2017-05-11
MX2018005590A (es) 2018-08-01
PH12018500969A1 (en) 2018-12-17
AU2016348173A1 (en) 2018-05-10
BR112018008008A2 (pt) 2018-10-30
JP2018537434A (ja) 2018-12-20
EP3370548A1 (en) 2018-09-12
US9730969B2 (en) 2017-08-15

Similar Documents

Publication Publication Date Title
HK1259179A1 (zh) 肉類替代品
ZA201800687B (en) Animal feed compositions and uses thereof
SG11201803127TA (en) Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
HK1252026A1 (zh) 藥物組合及其應用
GB2562270B (en) Skin barrier composition
PL3280423T3 (pl) Kompozycje i sposoby do synergistycznego leczenia glikokaliksu
HK1249025A1 (zh) 口服食物激發膳食製劑
GB201600990D0 (en) Pharmaceutical or nutritional combination
PL3331377T3 (pl) Wysokoenergetyczna i wzbogacona w białko kompozycja odżywcza
GB2546439B (en) Ezrin-derived peptides and pharmaceutical compositions thereof
HK1245113A1 (zh) 藥物組合物及其用途
IL258755A (en) Low dose oral dipyridamole compositions and compositions and uses thes thereof
IL258431A (en) Deimmunized therapeutic compositions and methods
PL3347444T3 (pl) Kompozycje tłuszczowe
GB201603591D0 (en) Improved promotors and compositions
ZA201808051B (en) Tablet-in-tablet pharmaceutical composition comprising cyclophosphamide and capecitabine
ZA201801218B (en) Medicament and nutritional supplement
ZA201803798B (en) Pet food compositions
IL258592A (en) Morphinan derivative and medical usage thereof
GB2544323B (en) Skin barrier composition
GB201522980D0 (en) The health food for memory improvement and its preparation method
GB201604865D0 (en) Patient fall prevention
GB201521083D0 (en) Compositions for treatment and methods thereof
GB201511410D0 (en) Pain supressars
AU364162S (en) Curved tissue fastening device